Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 ...

For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic ...

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...

The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor ...

Taking a GLP-1 receptor agonist was associated with a lower risk for cirrhosis and related complications in patients with ...

To add more protein to your life, you can consider adding animal proteins like eggs, cottage cheese, Greek yogurt, and ...

Reviewed by Dietitian Emily Lachtrupp, M.S., RD Ever since berberine made headlines last year for being touted as “nature’s ...

Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

Centene's Medicaid revenue fell slightly in the third quarter as costs outpaced the payment increases states implemented.

Ozempic is one of several medications, called glucagon-like peptide-1 receptor agonists or GLP-1 RAs, that are prescribed to ...